Loading...

Lack of Clinically Significant Pharmacokinetic Interaction between the Thrombopoietin Receptor Agonist Eltrombopag and Hepatitis C Virus Protease Inhibitors Boceprevir and Telaprevir

Eltrombopag is an orally bioavailable thrombopoietin receptor agonist approved for the treatment of thrombocytopenia associated with chronic immune (idiopathic) thrombocytopenic purpura and chronic hepatitis C virus (HCV) infection. This study evaluated the potential drug-drug interactions between e...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Wire, Mary Beth, Fang, Lei, Hussaini, Azra, Kleha, Joseph F., Theodore, Dickens
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249398/
https://ncbi.nlm.nih.gov/pubmed/25155600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03091-14
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!